Leading Investors Divest, Yet Stocks Continue to Rise: An Analysis
Money

Leading Investors Divest, Yet Stocks Continue to Rise: An Analysis

authorBy Ramit Sethi
DateJun 25, 2026
Read Time4 min
This article explores the intriguing market phenomenon where major institutional investors liquidate their positions in certain stocks, only for those same stocks to subsequently appreciate in value. It delves into the cases of Alphabet, Delta Air Lines, and Southwest Gas, which saw significant sell-offs by legendary investors, contrasting these moves with sustained positive analyst outlooks and robust market performance. The piece aims to provide clarity for retail investors navigating such mixed signals in the financial landscape.

Navigating the Market: When Giants Exit and Stocks Defy Expectations

Noteworthy Exits by Financial Titans

Three distinguished investors—Stanley Druckenmiller, David Tepper, and Carl Icahn—reduced their holdings in Alphabet (NASDAQ: GOOGL), Delta Air Lines (NYSE: DAL), and Southwest Gas (NYSE: SWX) during the first quarter of 2026, as revealed by their 13F filings. Despite these high-profile divestments, these companies' shares have continued to advance, challenging conventional market wisdom.

Discrepancy Between Investor Actions and Market Momentum

The market's reaction to these divestitures has been counterintuitive. Alphabet's stock, for instance, has gained over 20% since Druckenmiller's complete exit. Delta Air Lines, sold by Tepper at approximately $67, is now trading significantly higher. Similarly, Southwest Gas has seen an increase following Icahn's liquidation of his stake. This divergence prompts a closer look into why these stocks continue to perform well despite the departure of influential investors.

Examining Analyst Projections and Market Performance

Wall Street analysts maintain a strong bullish stance on all three companies. Alphabet boasts an average price target of $432.83, while Delta and Southwest Gas have targets of $82.97 and $99.25, respectively. These targets, coupled with the stocks' post-divestment gains—20.2% for Alphabet, 36.7% for Delta, and 2.9% for Southwest Gas—underscore a persistent confidence in their future prospects.

Underlying Financial Strength: A Closer Look at Fundamentals

The strong performance is backed by solid fundamentals. Alphabet reported a substantial earnings beat in Q1 2026, driven by impressive growth in Google Cloud revenue and a massive backlog. Delta Air Lines also showcased robust financial health with a significant year-over-year increase in adjusted EPS and optimistic guidance for the upcoming quarter. Southwest Gas reaffirmed its positive EPS outlook, projecting a healthy CAGR through 2030.

Alphabet: Balancing Innovation with Investment

Alphabet's bull case rests on its attractive forward P/E and high-profit margins, fueled by rapid AI monetization. However, a bear argument points to substantial capital expenditure guidance for 2026, which could impact free cash flow, and a significant portion of Q1 net income derived from unrealized equity gains.

Delta Air Lines: Growth Amidst Operational Challenges

For Delta, the bullish outlook is supported by its forward P/E, strong premium revenue growth, and substantial remuneration from American Express. Conversely, concerns arise from the stock trading near or above consensus targets, anticipated increases in fuel costs, and planned reductions in capacity growth.

Southwest Gas: Utility Stability Versus Market Valuation

Southwest Gas benefits from strong demand for its Great Basin pipeline and its classification as a regulated utility with an upgraded S&P rating. The bear case highlights a recent Q1 EPS miss, a relatively high trailing P/E for a utility, and delays in critical regulatory decisions.

Reconciling Smart Money Exits with Ongoing Market Optimism

The divestments by these seasoned investors, as reflected in their 13F filings, are typically backward-looking snapshots and often driven by portfolio rebalancing, risk management, or fund-specific strategies rather than a negative long-term view of the underlying businesses. For instance, Tepper secured profits from Delta, Icahn concluded an activist campaign at Southwest Gas, and Druckenmiller is known for his dynamic, concentrated bets. These actions are more indicative of individual portfolio decisions than a fundamental red flag for the companies themselves.

Investment Horizons: A Key Differentiator

The divergence between investor exits and analyst optimism often stems from differing time horizons. Hedge funds operate on quarterly cycles, managing short-term drawdown risks. In contrast, sell-side analysts typically provide 12-month fundamental outlooks. While Alphabet's target price still suggests considerable upside, Delta and Southwest Gas are trading closer to or above their consensus targets, implying a potentially reduced margin of safety for new investments compared to Alphabet.

Strategic Implications for Retail Investors

For retirement-focused investors, Alphabet continues to offer a clear fundamental growth path. However, for Delta Air Lines and Southwest Gas shareholders, the current valuations, hovering around or exceeding analyst targets, might signal a need for careful consideration. The key takeaway for retail investors is to understand that institutional divestments are not necessarily calls to sell but rather reflect complex portfolio management strategies. Evaluating a company's fundamentals and market position remains crucial for making informed investment decisions.

More Articles
Money
Mirum Pharmaceuticals: A Potential Growth Story in Rare Diseases?
Mirum Pharmaceuticals is gaining attention as a promising entity in the rare disease sector, particularly following new data on its FOP treatment, zilurgisertib. Despite a Phase 2b study not meeting its primary endpoint, updated findings show encouraging clinical activity, prompting Citizens to raise its price target for MIRM. The company also recently granted inducement awards to new hires, aligning with its growth trajectory in developing therapies for liver and metabolic disorders caused by bile acid dysfunction.
By Bola SokunbiJun 25, 2026
Money
Upstream Bio: A Promising Biotech for Inflammatory Diseases
Upstream Bio, Inc. (NASDAQ: UPB) is gaining recognition as a potential opportunity in the biotech sector. Analyst Matthew Caufield initiated coverage with a 'Buy' rating and a $36 price target, highlighting the company's lead candidate, verekitug, an antibody targeting the thymic stromal lymphopoietin receptor. Recent Phase 2 trial results for verekitug in chronic rhinosinusitis with nasal polyps further support its potential, showing significant improvement and addressing an unmet medical need.
By Scott PapeJun 25, 2026
Money
Bed Bath & Beyond's Strategic Initiatives: Coupon Hunt and Home Services Expansion
Bed Bath & Beyond is actively working to rebuild customer engagement and expand its service offerings. The company recently launched a 'Legendary Coupon Hunt' to reconnect with long-time customers, offering a significant home transformation prize. Additionally, BBBY acquired Installed Right and SFV Services to bolster its home services platform, adding installation, renovation, and project management capabilities, which is expected to boost revenue and adjusted EBITDA.
By Dave RamseyJun 25, 2026
Money
Edgewise Therapeutics Sees Price Target Boosted to $59 Following Positive HCM Trial Outcomes
Edgewise Therapeutics (EWTX) had its price target raised to $59 by RBC Capital, which maintained an Outperform rating. This increase comes after favorable 12-week results from the '7500 HCM trial, demonstrating promising safety and effectiveness. RBC Capital anticipates these findings could pave the way for a Phase 3 trial without requiring titration echocardiograms, enhancing real-world applicability. The firm also highlighted EWTX's broader cardiology potential, foreseeing substantial long-term expansion from its '7500 program and overall pipeline. The company recently divested its muscular dystrophy business for $2.65 billion, allowing it to concentrate on its cardiovascular portfolio.
By Mr. Money MustacheJun 25, 2026
Money
AI's Impact on Energy: T1 Energy's Solar Solutions
T1 Energy, a U.S. solar manufacturer, is gaining attention for its comprehensive domestic solar supply chain, positioning it advantageously amid federal clean energy tax credit policies. The company, which produces solar modules and is developing a solar cell factory, primarily serves utility-scale solar developers. Its growth is closely tied to the surging electricity demands from AI data centers, with its manufacturing facilities strategically located in Texas, a key region for solar expansion. Despite short-seller allegations regarding undisclosed China ties and accounting practices, T1 Energy has seen its stock rebound sharply, reflecting market confidence. Analysts highlight the critical role of utility-scale solar as the most cost-effective and rapid solution for new electricity generation, especially when compared to traditional alternatives like natural gas and nuclear plants, which face longer deployment times and higher costs.
By Mr. Money MustacheJun 25, 2026